GlassScriptPhysician profile
Erin Herendeen
NPI 1588991574
$512.69
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.18 | 2021-2022 | |
| Novo Nordisk INC | $207.14 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $29.25 | 2021 | |
| Glaxosmithkline, LLC. | $15.55 | 2021 | |
| Dexcom, INC. | $13.95 | 2021 | |
| Ethicon US, LLC | $13.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.96 | 2021 | |
| Sanofi Pasteur INC. | $11.71 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Herendeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.